For more bakery strategies, food industry insights, and profit-building tactics, visit the Plastic Container City blog
In some cases, insurance may cover removal of the extra skin across the abdomen, which can improve quality of life and body shape
Suitability considerations: Consistent with class precedents for GLP-1-based therapies, retatrutide would not be expected to be suitable during pregnancy or breastfeeding, and paediatric data are currently lacking
Semaglutide is a prescription drug available as a once-weekly injection (Ozempic, Wegovy) or a once-daily tablet (Ozempic, Rybelsus)
Evidence Summary Current evidence supports the following conclusions: GLP-1 drugs reduce caloric intake Reduced intake may reduce micronutrient consumption Delayed gastric emptying does not equal malabsorption Rapid weight loss may increase lean mass vulnerability Long-term micronutrient outcome data remain limited There is mechanistic plausibility for nutritional risk in certain populations, but no strong evidence of universal depletion across all patients
What should I do if laxatives and hydration aren't working